AFTI works to improve the U.S.-India commercial relationship that has been damaged over the last several years as policymakers and courts in India have engaged in a persistent pattern of discrimination, hurting a wide range of manufacturing and services industries and costing U.S. jobs. While U.S.-India dialogue on a range of issues has improved over the last year since Prime Minister Narendra Modi was elected, it has not resulted in concrete action or substantial improvements in policy. In some cases, the Modi government has even created a more difficult and discriminatory environment by raising tariffs, enforcing food product review processes and requirements outside international norms, and imposing new burdensome testing requirements on information and communications technology imports. Administrative and court rulings in India continue to ignore internationally recognized rights, impose restrictions on medical devices, and deny or revoke patents on lifesaving medications. In 2014, U.S. trade with India totaled $67 billion, less than two percent of total U.S. trade. If India removed discriminatory barriers and improved intellectual property protection, however, U.S. exports to that country would likely rise by two-thirds (the equivalent of $14.4 billion, based on 2013 data) and U.S. investment would roughly double, according to a recent U.S. International Trade Commission report.India's failure to comply with international trade obligations is not only damaging exports and jobs in the United States, it is also harming India’s own economy. AFTI is urging the Trump Administration and the Modi government to intensify efforts to resolve these issues in order to foster economic reform and growth and develop a fairer and stronger U.S.-India trading relationship.
India to Western Tech Firms: To Sell It Here, Build It HereThe Wall Street Journal
I don’t think that India is preserving an incentive for innovation. If anything, recent Indian policies are sending a signal that intellectual property is tenuous in this country and will be granted only in those cases where it can benefit India. Thomas Friedman has taught us that the world is flat. It may well be. But, when it comes to drug pricing and intellectual property, the plane is severely tilted in India’s favor.India John LaMattina, Forbes.com
US-India Business Council, Information Technology Industry Council, Digital Europe and the Tele-communications Industry Association of US, amongst several others, warned this would represent an unprecedented interference in the procurement of commercial entities and be inconsistent with the country’s obligations to the World Trade Organisation.India bars foreign vendors from national broadband initiative Kalyan Parbat, Economic Times